Skip to content
PubMed This is a summary of 80 peer-reviewed journal articles Updated
Neurology

Paraneoplastic Polyneuropathy: A Patient Guide

At a Glance

Paraneoplastic polyneuropathy is an immune attack on peripheral nerves associated with cancer, not direct cancer spread to the nerves. Treating the underlying tumor, individualized immunotherapy, rehabilitation, and surveillance aim to stop progression, although nerve symptoms may persist.

Scope of this Guide: This guide addresses suspected or confirmed paraneoplastic peripheral nerve syndromes. It is important to know that most neuropathies are not paraneoplastic, and this guide cannot diagnose an occult cancer or replace urgent clinical care.

Paraneoplastic polyneuropathy (PPN) is a rare condition that occurs when your body’s immune system, in its effort to fight an underlying cancer, accidentally damages your peripheral nerves. This is not a case of cancer spreading directly to the nervous system; instead, it is a biological “mistaken identity.” The immune system identifies proteins on a tumor that resemble those in your healthy nerve cells and launches a cross-reactive attack, leading to rapid inflammation and nerve injury [1].

Because the immune system often detects a tumor before it is large enough to be seen on standard medical imaging, these neurological symptoms can sometimes act as an early warning sign, though many patients do not have an occult cancer. You may experience a “diagnostic odyssey,” searching for answers to unexplained pain, numbness, or a profound loss of balance—known as sensory ataxia—before a specific onconeural antibody is discovered in your blood or spinal fluid. This discovery shifts the medical focus toward a rigorous evaluation, as finding and treating the underlying cancer is usually the most critical step in stopping the immune attack [2].

Managing PPN requires a dual-track approach where oncologists and neurologists work in tandem. While the oncology team treats the tumor to remove the trigger for the immune response, the neurology team uses individualized immunotherapy to quiet the overactive immune system and protect the remaining nerve function. Timing is essential in this process, as starting treatment as early as possible provides the best chance of halting the progression of the disease and preventing permanent disability [3].

Living with this condition involves a transition into a unique form of survivorship. While successful treatment can often stabilize the disease, many people continue to manage long-term symptoms such as chronic nerve pain or mobility challenges. Recovery is a gradual process that involves not only medical intervention but also specialized rehabilitation and persistent cancer surveillance. Through this coordinated care, the goal is to stop the progression of the damage and help you maintain your independence and quality of life [4].

Common questions in this guide

What causes paraneoplastic polyneuropathy?
It happens when the immune system responds to an underlying cancer and mistakenly attacks the body’s peripheral nerves. It is not caused by cancer spreading directly into the nerves, and most neuropathies are not paraneoplastic.
What symptoms can paraneoplastic polyneuropathy cause?
Symptoms may include nerve pain, numbness, worsening balance, and sensory ataxia, a severe loss of coordination caused by reduced sensation. Mobility and everyday activities can become more difficult, and symptoms may appear before the cancer is found.
How do doctors look for paraneoplastic polyneuropathy and an underlying cancer?
Doctors consider the pattern and timing of nerve symptoms, test blood or spinal fluid for antibodies linked to cancer and nerve disease, and evaluate for a possible underlying tumor. A positive result can guide a more thorough cancer evaluation, but it does not prove that a person has an occult cancer.
Does finding a nerve-related antibody mean I definitely have cancer?
No. An antibody associated with paraneoplastic nerve disease can prompt a careful search for an underlying tumor, but many people with these symptoms do not have an occult cancer. Your care team may recommend continued evaluation or cancer monitoring based on your symptoms and results.
Why do I need both cancer and neurology care for this condition?
The oncology team treats the underlying tumor that may be driving the immune response, while the neurology team manages nerve inflammation and symptoms with individualized immune treatment. Coordinating both approaches is important because early treatment offers the best chance of stopping further nerve damage.
Can nerve damage from paraneoplastic polyneuropathy improve?
Treatment can stabilize the condition and may prevent additional nerve damage, but recovery is often gradual and some symptoms can remain. Rehabilitation and mobility support, along with ongoing cancer surveillance, may help protect independence and quality of life.

Get notified when new evidence is published on paraneoplastic polyneuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (4)
  1. 1

    Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.

    Shelly S, Dubey D, Mills JR, Klein CJ

    Handbook of clinical neurology 2024; (200()):239-273 doi:10.1016/B978-0-12-823912-4.00020-7.

    PMID: 38494281
  2. 2

    Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis.

    Villagrán-García M, Farina A, Muñiz-Castrillo S, et al.

    Brain communications 2023; (5(5)):fcad247 doi:10.1093/braincomms/fcad247.

    PMID: 37794924
  3. 3

    Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies.

    Antoine JC, Robert-Varvat F, Maisonobe T, et al.

    Journal of the neurological sciences 2016; (361()):187-91.

    PMID: 26810539
  4. 4

    [Paraneoplastic cerebellar degeneration (PCD) - an interdisciplinary challenge in neurology, oncology and palliative care].

    Burger S, Lorenzl S

    Wiener medizinische Wochenschrift (1946) 2018; (168(7-8)):193-198 doi:10.1007/s10354-018-0624-4.

    PMID: 29411193

This page is for informational purposes only and does not constitute medical advice or diagnose paraneoplastic polyneuropathy or an underlying cancer. Seek prompt care from your neurologist and oncology team for new or worsening nerve symptoms.